“Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review”. 2024. The Medical Journal of General Medicine, vol. 1, no. 1, Oct. 2024, pp. 1-16, https://medicaljournalinternational.org/tmjgm/article/view/1.